Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
Pēteris Alberts(Maxygen (United States)), Lars Abrahmsén(Swedish Orphan Biovitrum (Sweden)), Marianne Forsgren(Karolinska University Hospital), Birgitta Öhman(Swedish Orphan Biovitrum (Sweden)), Christel Larsson(University of Gothenburg), Gunnel Klingström(Swedish Orphan Biovitrum (Sweden)), Yuko Rönquist-Nii(Swedish Orphan Biovitrum (Sweden)), Linda Engblom(Swedish Orphan Biovitrum (Sweden)), N. Edling(Swedish Orphan Biovitrum (Sweden))
Cited by 259
Related Papers
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1
|Journal of Medicinal Chemistry|2002|211
The advent of oncolytic virotherapy in oncology: The Rigvir® story
|European Journal of Pharmacology|2018|179
Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults
|Journal of Neurology|2005|169
Mobile-based intervention intended to stop obesity in preschool-aged children: the MINISTOP randomized controlled trial ,
|American Journal of Clinical Nutrition|2017|162